Harvard Bioscience
HBIO
#8485
Rank
C$0.15 B
Marketcap
$3.65
Share price
-1.10%
Change (1 day)
-37.56%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of June 2024 : C$5.49 M

According to Harvard Bioscience's latest financial reports the company has C$5.49 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$5.68 M-7.13%
2022-12-31C$6.11 M-38.2%
2021-12-31C$9.89 M-6.67%
2020-12-31C$10.6 M-1.84%
2019-12-31C$10.8 M-3.09%
2018-12-31C$11.14 M70.8%
2017-12-31C$6.52 M-13.2%
2016-12-31C$7.52 M-19.7%
2015-12-31C$9.36 M-42.87%
2014-12-31C$16.39 M-40.21%
2013-12-31C$27.41 M33.01%
2012-12-31C$20.61 M13.1%
2011-12-31C$18.22 M-7.6%
2010-12-31C$19.72 M12.86%
2009-12-31C$17.47 M4.41%
2008-12-31C$16.73 M-4.57%
2007-12-31C$17.53 M60.99%
2006-12-31C$10.89 M22.61%
2005-12-31C$8.88 M-41.28%
2004-12-31C$15.13 M40.37%
2003-12-31C$10.77 M-55.43%
2002-12-31C$24.18 M-48.34%
2001-12-31C$46.81 M-12.76%
2000-12-31C$53.66 M1452.78%
1999-12-31C$3.45 M134.87%
1998-12-31C$1.47 M